Browsing by Author "Uzun A."
Now showing 1 - 2 of 2
Results Per Page
Sort Options
Item Electrochemical, mechanical, and antibacterial properties of the AZ91 Mg alloy by hybrid and layered hydroxyapatite and tantalum oxide sol-gel coating(Walter de Gruyter GmbH, 2023) Albayrak S.; Gül C.; Emin N.; Gökmen U.; Karakoç H.; Uzun A.; Çinici H.The corrosion and bacterial behavior of AZ91 magnesium alloy coated with sol-gel-deposited amorphous tantalum oxide and hydroxyapatite have been investigated. The objective was to assess the potential suitability of AZ91 for permanent prosthesis applications. The coatings were applied in layered and hybrid configurations and characterized using various techniques including X-ray diffractometry, Fourier transform infrared spectroscopy, scanning electron microscopy/energy dispersive spectrometry, and drop analyses. The antibacterial properties were evaluated through interactions with Staphylococcus aureus and Escherichia coli strains. Mechanical properties and adhesion were determined via linear scratch tests, and electrochemical corrosion tests were conducted in different media. The release of aluminum ions from the samples in Dulbecco's Modified Eagle's Medium was monitored over 28 days. The findings revealed that the amorphous tantalum oxide coating, particularly in combination with hydroxyapatite, improved antibacterial properties and positively influenced corrosion and scratch resistance. The layered and hybrid coatings demonstrated the highest corrosion resistance. The release of aluminum ions remained within acceptable levels in the tested medium. Overall, the study provides valuable insights into the potential of sol-gel coatings on AZ91 for prosthetic applications, considering antibacterial behavior, corrosion resistance, and aluminum release. © 2023 Walter de Gruyter GmbH, Berlin/Boston.Item Clinical and Demographic Characteristics of Treatment Requiring Retinopathy of Prematurity in Big Premature Infants in Turkiye: Report No. 1 (BIG-ROP Study)(S. Karger AG, 2024) Özdek Å.; Ozdemir H.B.; Ozen Tunay Z.; Bayramoglu S.E.; Alyamac Sukgen E.; Klr N.; Koç E.; Ekinci D.Y.; Sayin N.; Ceylan N.A.; Cebeci Z.; Çelik G.; Kizilay O.; Demir S.T.; Yildiz M.; Öztürk T.; Bekmez S.; Eris E.; Çömez A.; Mayali H.; Kabatas E.U.; Satirtav G.; Ögreden T.; Vural A.; Onur I.U.; Yeter D.Y.; Gönc T.; Tanidir S.T.; Akdogan M.; Çelemler P.; Beyazyildiz E.; Beyazyildiz Ö.; Acar D.E.; Özbay E.K.; Özcan Y.; Keles S.; Yildirim M.; Uzun A.; Dikci S.; Sari A.; Kara C.; Petriçli I.S.; Comba Ö.B.S.; Albayrak S.; Ersan B.A.; Bilgin B.; Çeliker H.; Sahin O.; Seymen Z.; Alaluf A.; Kaymak N.Z.; Oral A.Y.; Kerimoglu H.; Ünsal A.I.A.; Hirfanoglu I.M.; Tayman C.; Mert M.K.; Çetinkaya M.; Karatekin G.; Uslu S.; Özkan H.; Tüzün F.; Yildirim T.G.; Yurttutan S.; Dinlen N.F.; Bezirganoglu H.; Altinhan H.; Salihoglu Ö.; Tun G.; Karakurt D.G.; Bas A.Y.; Demiroglu Ö.B.; Aygün C.; Tekgündüz K.S.; Ceylan M.; Özdemir R.; Zübahiroglu U.; Özkiraz S.; Cömert S.; Akcan A.B.Introduction: The aim of the study was to analyse the clinical and demographic features of infants with gestational age (GA) of 32-37 weeks and birth weight (BW) of >1,500 g who developed treatment requiring retinopathy of prematurity (ROP). Methods: Data on the infants with a GA of 32-37 weeks and BW >1,500 g who developed treatment requiring ROP (TR-ROP) were collected retrospectively from the 33 ROP centres in Turkiye. GA, BW, type of hospital, neonatal intensive care units (NICUs) level, presence of an ophthalmologist and neonatologist in the same hospital, length of stay in NICU, duration of oxygen therapy, comorbidities, type of ROP, and timing for TR-ROP development were analysed. Results: A total of366 infants were included in the study. Mean GA and BW were 33 1 weeks and 1,896 316 g, respectively. Duration of hospitalization was 3-4 weeks in 46.8% of them. The first ROP examination was performed at postnatal 4-5 weeks in 80.3% of infants, which was significantly later in level 2 and lower NICUs and non-university clinics. At the first ROP examination, any stage of ROP was detected in 90.9% and TR-ROP was detected in 15.3% of the infants. The mean postnatal week of TR-ROP development was 6.16 2.04. Conclusion: Routine ROP screening thresholds need to be expanded in hospitals with suboptimal NICU conditions considering the development of TRROP in more mature and heavier preterm infants. The first ROP examination should be earlier than the fourth postnatal week. 2024 S. Karger AG, Basel. © 2024 S. Karger AG. All rights reserved.